119 related articles for article (PubMed ID: 11014093)
1. [Aromatase inhibitors in the treatment of breast cancer].
Perey L
Rev Med Suisse Romande; 2000 Jun; 120(6):495-500. PubMed ID: 11014093
[No Abstract] [Full Text] [Related]
2. The current status of aromatase inhibitors in the management of breast cancer.
Baum M; Buzdar A
Surg Clin North Am; 2003 Aug; 83(4):973-94. PubMed ID: 12875605
[TBL] [Abstract][Full Text] [Related]
3. Toremifene and letrozole for advanced breast cancer.
Med Lett Drugs Ther; 1998 Apr; 40(1024):43-5. PubMed ID: 9580744
[No Abstract] [Full Text] [Related]
4. Letrozole in breast cancer.
Shahab N
N Engl J Med; 2004 Feb; 350(7):727-30; author reply 727-30. PubMed ID: 14971058
[No Abstract] [Full Text] [Related]
5. [Aromatase inhibitors].
Feutrie ML; Bonneterre J
Bull Cancer; 1999 Oct; 86(10):821-7. PubMed ID: 10572233
[TBL] [Abstract][Full Text] [Related]
6. Aromatase inhibitors and inactivators in breast cancer.
Lønning PE
BMJ; 2001 Oct; 323(7318):880-1. PubMed ID: 11668120
[No Abstract] [Full Text] [Related]
7. [Aromatase inhibitors: anastrozole versus tamoxifen as first-ine therapy for advanced postmenopausal breast cancer].
Bergmann L
Strahlenther Onkol; 2001 May; 177(5):273-4. PubMed ID: 11398617
[No Abstract] [Full Text] [Related]
8. [Two new therapeutic principles in the management of breast cancer and colorectal cancer: selective oral aromatase inhibition and thymidilate synthase inhibition].
Internist (Berl); 1997 Mar; 38(3 Suppl Selektive):1-16. PubMed ID: 9541667
[No Abstract] [Full Text] [Related]
9. [Aromatase inhibitors for treatment of advanced breast cancers].
Sonoo H
Nihon Rinsho; 2000 Apr; 58 Suppl():322-7. PubMed ID: 11026013
[No Abstract] [Full Text] [Related]
10. [Aromatase inhibitors: a review of clinical trials].
Kerbrat P; Lefeuvre C
Bull Cancer; 2000 Dec; 87 Spec No():31-39. PubMed ID: 11250606
[TBL] [Abstract][Full Text] [Related]
11. A better medication for treating breast cancer?
Johns Hopkins Med Lett Health After 50; 2002 May; 14(3):3. PubMed ID: 12004835
[No Abstract] [Full Text] [Related]
12. The Letrozole Breast Cancer Trial: clinical implications and remaining questions.
Chen WY; Manson JE
Womens Health Issues; 2004; 14(1):7-10. PubMed ID: 15001182
[No Abstract] [Full Text] [Related]
13. [The role of aromatase inhibitors in the treatment of breast neoplasms. An evaluation of clinical efficacy and the tolerability profile].
Porpiglia M; Genta F; Vicelli R; De Nicola B; Ferraris F; Piccinno R; Benedetto C
Minerva Ginecol; 2002 Apr; 54(2):115-31. PubMed ID: 12032450
[TBL] [Abstract][Full Text] [Related]
14. [Aromatase inhibitors of the 3rd generation. What can the "pill against breast cancer" really do?].
Junker A; Wiedemann GJ; Possinger K
MMW Fortschr Med; 2002 Jan; 144(5):46-8. PubMed ID: 11883037
[TBL] [Abstract][Full Text] [Related]
15. New breast cancer drug.
Brink S
US News World Rep; 2001 Dec; 131(26):52. PubMed ID: 11793594
[No Abstract] [Full Text] [Related]
16. Drugs may improve long-term outcomes after breast cancer.
Mayo Clin Health Lett; 2004 Mar; 22(3):4. PubMed ID: 15000065
[No Abstract] [Full Text] [Related]
17. Survival in patients with metastatic breast cancer: analysis of randomized studies comparing oral aromatase inhibitors versus megestrol.
Messori A; Cattel F; Trippoli S; Vaiani M
Anticancer Drugs; 2000 Oct; 11(9):701-6. PubMed ID: 11129731
[TBL] [Abstract][Full Text] [Related]
18. The bone substudy of MA.27: does bone make a difference?
Mathew A; Brufsky A
Lancet Oncol; 2014 Apr; 15(4):375-7. PubMed ID: 24636209
[No Abstract] [Full Text] [Related]
19. Beating breast cancer.
Fricker J
Nurs Stand; 2004 Aug 11-17; 18(48):15. PubMed ID: 15366393
[No Abstract] [Full Text] [Related]
20. [The ATAC study on adjuvants in breast cancer].
Bravi S
Suppl Tumori; 2004; 3(4):S15. PubMed ID: 15206200
[No Abstract] [Full Text] [Related]
[Next] [New Search]
